Kriska BioTech ApS: Financial statements 2023
CVR: 37591971
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
Kriska BioTech ApS (CVR 37591971) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -26,043 and a net result of DKK -61,277 compared with DKK -120,331 the year before. Equity in the 2023 report amounted to DKK -331,026.
- Gross Profit
- DKK -26,043
- Profit/Loss
- DKK -61,277
- Equity
- DKK -331,026
- Total Assets
- DKK 158,775
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -26 t. | -61 t. | -331 t. | - |
| 2022 | - | -88 t. | -120 t. | -270 t. | - |
| 2021 | - | 39 t. | 128 | -149 t. | 1 |
| 2020 | - | -27 t. | -55 t. | -150 t. | 1 |
| 2019 | - | -33 t. | -175 t. | -94 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Kriska BioTech ApS has published its annual report for 2022. Gross profit came to DKK -87,515, and the net result was DKK -120,331.
About Kriska BioTech ApS
Kriska BioTech ApS is a Danish company of the type Anpartsselskab based in Gedsted, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Karsten Kristoffersen. The company is owned by Hans Karsten Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -25,405 and a net result of DKK -49,612 compared with DKK -44,384 the year before. Equity in the 2025 report amounted to DKK -425,023.